Cite
MLA Citation
P M Irving et al.. “DOP84 Risankizumab maintenance therapy results in sustained improvements in endoscopic outcomes in patients with moderate to severe Crohn's Disease: Post-hoc analysis from the phase 3 study FORTIFY.” Journal of Crohn's and colitis, vol. 16, n.d., pp. i127–i128. http://access.bl.uk/ark:/81055/vdc_100150515167.0x00001a